Through a clinic-pathological study, Zeng et al., found that AT3 protein and mRNA expression was lower in tumor tissues of gastric cancer than in peritumor tissues, and this down-regulating expression significantly affected clinic-pathological features of gastric cancer [14]. This evidence concerns the gene ATXN3 and gastric cancer.